| dc.contributor.author | Akpolat, T | |
| dc.contributor.author | Yilmaz, E | |
| dc.contributor.author | Ozdogan, H | |
| dc.contributor.author | Melikoglu, M | |
| dc.contributor.author | Altiok, E | |
| dc.contributor.author | Ozen, S | |
| dc.date.accessioned | 2020-06-21T15:37:11Z | |
| dc.date.available | 2020-06-21T15:37:11Z | |
| dc.date.issued | 2005 | |
| dc.identifier.issn | 0392-856X | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/21172 | |
| dc.description | Melikoglu, Meltem Alkan/0000-0001-7519-9470; YILMAZ, Engin/0000-0001-8873-7645; | en_US |
| dc.description | WOS: 000228988300026 | en_US |
| dc.description | PubMed: 15895905 | en_US |
| dc.description.abstract | … | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | Clinical & Exper Rheumatology | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Do MEFV mutations play a role in the development of Behcet's disease related amyloidosis? | en_US |
| dc.type | letter | en_US |
| dc.contributor.department | OMÜ | en_US |
| dc.identifier.volume | 23 | en_US |
| dc.identifier.issue | 2 | en_US |
| dc.identifier.startpage | 273 | en_US |
| dc.identifier.endpage | 274 | en_US |
| dc.relation.journal | Clinical and Experimental Rheumatology | en_US |
| dc.relation.publicationcategory | Diğer | en_US |
